losartan potassium and hydrochlorothiazide
- Product NDC
- 71610-671
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- losartan potassium and hydrochlorothiazide
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA204832
- Marketing category
- ANDA
- Substance
- HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71610-671-30 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-30) | 2022-11-02 | | No | Historical |
| 71610-671-45 | 45 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-45) | 2022-11-02 | | No | Historical |
| 71610-671-53 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-53) | 2022-11-03 | | No | Historical |
| 71610-671-60 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-60) | 2022-11-02 | | No | Historical |
| 71610-671-70 | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-70) | 2022-11-02 | | No | Historical |
| 71610-671-80 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (71610-671-80) | 2022-11-02 | | No | Historical |